Freedom Broker Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $27
Freedom Broker analyst Ilya Zubkov initiates coverage on Arcturus Therapeutics (NASDAQ: ARCT ) with a Buy rating and announces Price Target of $27.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.